Intelligence · Patent portfolio
Rani Therapeutics Holdings Patents
Full USPTO pharma patent portfolio for Rani Therapeutics Holdings — grant dates, expiration, and drug cross-links.
- Patents
- 148
- Expiring ≤24m
- 1
Quick answer
Rani Therapeutics Holdings has 148 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
-
US 6689404
Agent for regulating iodine exchange or for preventing iodine-deficit conditions
expired -
US 6629970
Method of restoring endothelium of cornea
expired -
US 6518247
Method for producing an antitumoral agent and antitumoral agent thus obtained
expired -
US 6261752
Alkaline soluble mixture composed of cellulose derivatives
expired
Frequently asked questions
How many patents does Rani Therapeutics Holdings have?
148 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Rani Therapeutics Holdings patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources · Patent directory